Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Mouse anti-Human IgD Antibody

FACS Monoclonal IA6-2 IgG2a unconjugated
Catalog No. ABIN7670067
-15% Promotion 2026
$19,227.00
$22,620.00
save $3,393.00 (-15 %)
Plus shipping costs $50.00
100 mg
Shipping to: United States
Delivery in 11 to 14 Business Days

Quick Overview for Mouse anti-Human IgD Antibody (ABIN7670067)

Target

IgD

Clonality

  • 29
  • 28
Monoclonal

Application

  • 29
  • 25
  • 12
  • 11
  • 8
  • 7
  • 6
  • 5
  • 4
  • 3
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

IA6-2

Isotype

IgG2a, kappa
  • Reactivity

    • 36
    • 16
    • 6
    Human

    Host

    • 19
    • 15
    • 10
    • 9
    • 5
    Mouse

    Purpose

    Purified Anti-Human IgD Antibody[IA6-2]
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    ≥ 1 mg/mL

    Buffer

    Phosphate buffered solution, pH 7.2, containing 0.05 % proclin 300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    avoid freeze / thaw cycles.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles.

    Expiry Date

    12 months
  • Target

    IgD

    Target Type

    Antibody

    Background

    IGD,Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen. IgD is the major antigen receptor isotype on the surface of most peripheral B cells, where it is coexpressed with IgM. The membrane-bound IgD (mIgD) induces the phosphorylation of CD79A and CD79B by the Src family of protein tyrosine kinases. Soluble IgD (sIgD) concentration in serum is below those of IgG, IgA, and IgM but much higher than that of IgE. IgM and IgD molecules present on B cells have identical V regions and antigen-binding sites. After the antigen binds to the B cell receptor, the secreted form sIgD is shut off. IgD is a potent inducer of TNF, IL1B, and IL1RN. IgD also induces release of IL6, IL10, and LIF from peripheral blood mononuclear cells. Monocytes seem to be the main producers of cytokines in vitro in the presence of IgD

    UniProt

    P0DOX3
You are here:
Chat with us!